The purpose of this article is to show the feasibility of the 'Advanced [retinal pigment epithelium] rPe analysis' software tool to measure drusen area and volume as well as the area of geographic atrophy (gA) in patients with dry age-related macular degeneration (AMD). The source data from spectral domain optical coherence tomography (sD-ocT) images obtained from three patients with confirmed dry AMD using cirrus™ hD-ocT (carl Zeiss Meditec) were re-evaluated with the new software analysis tool Advanced rPe analysis. The area of gA as well as drusen area and volume were measured and analysis of results were presented along with calculated values in two clearly arranged screens. changes between visits were easily detectable and could be followed over time. results correlated well with clinical observation. The conclusion reached was that the new Advanced rPe analysis software allows the automated, objective and quantitative assessment of atrophic lesions and drusen. it thus could prove to be useful in determining disease stages as well as prognosis more precisely, and provides the opportunity to monitor the effectiveness of new therapies in clinical trials. 
There are two forms of AMD: dry AMD (dAMD) which accounts for about 80 % of all cases of AMD, and neovascular AMD (nAMD). early stage AMD is characterised by soft drusen (protein and lipid deposits between retinal pigment epithelium [rPe] and Bruch's membrane) and pigment abnormalities (hyper-or hypopigmentation). Visual acuity is usually not deteriorated in early stages of AMD. however, they can progress to late stages of AMD: geographic atrophy (gA; late stage of dAMD) or neovascular AMD. Vision loss due to AMD is mainly attributable to these advanced forms. it is estimated that due to demographic changes, in 2020 the vision-threatening advanced forms will increase by more than 50 %. 5 Thus, a better understanding of the pathogenesis may lead to the development of new powerful therapies and is a matter of public and economic concern.
While there are several therapeutic approaches for nAMD, so far there are no established guidelines for dry AMD treatment. Although vitamin supplementation can slow the progression of dAMD in advanced forms, uncritical administration is not advisable due to possible adverse reactions. 6, 7 new drugs and advanced concepts for the treatment of dry AMD are waiting for further investigation. [8] [9] [10] [11] however, their evaluation of efficacy against dry AMD turns out to be difficult and time consuming. in contrast to nAMD, patients with dry AMD can maintain good central visual acuity until the disease progresses into the foveal centre. Thus, visual acuity might not be an appropriate clinical end-point in early stage clinical trials to determine drug efficacy against dry AMD. Therefore, new reliable clinical trial end-points enabling efficacy evaluation in the shortest period of time are needed. furthermore, diagnostic methods should be established which allow for reliable, objective, automated and quantitative assessment of disease progression in large patient populations.
As eyes with soft indistinct drusen or retinal pigmentary abnormalities at baseline are more likely to develop late AMD as compared to eyes without these lesions, 12 two encouraging options to monitor progression of dry AMD are the volumetric assessment of drusen as well as localisation and quantitative assessment of atrophic lesions in gA. 
Advanced RPE Analysis Tool
The Advanced rPe analysis software analysis tool is part of the new 
Retinal Pigment Epithelium Elevation Map
The rPe elevation map is used to automatically determine drusen area and volume. it is important to understand that rPe segmentation is used as the starting point for the drusen analysis. so strictly speaking this analysis detects elevations in the rPe. To identify elevations, a curve is fitted to the rPe segmentation that seeks to exclude deformations of the rPe and follow the curvature of the eye.
The region between the rPe segmentation and the curve fit is designated as rPe elevation. To allow for some variability in fitting, only areas where the elevation exceeds 10 pixels (19.5 µm) are used for calculations of rPe elevation area and volume. The rPe elevation map is an en face image presented in a pseudo-colour map using a colour scale that highlights elevations above 20 µm. This map is presented as a transparent image overlaying the ocT fundus.
Transparency is preset at 50 %, although it can be adjusted manually.
Sub-retinal Pigment Epithelium Slab
The sub-rPe slab is a 6 by 6 mm image that represents a sum of the ocT reflectivity values measured beneath the rPe. The sub-rPe slab tends to be brighter in areas where significant ocT light penetrates below the rPe and returns to be collected. The image tends to be dimmer in areas of the retina where the rPe is intact because the rPe is highly scattered and absorbing and tends to prevent light from penetrating and returning to be detected by the ocT device. When the rPe has atrophied, the penetration of light beneath the rPe is increased, and the subsequent bright area on the sub-rPe slab can be 
Presentation of Analysis Results
Within • area of rPe elevations (mm 2 ) within 3 and 5 mm circle;
• volume of rPe elevations (mm 3 ) within 3 and 5 mm circle;
• area of sub-rPe illumination in 5 mm circle; and
• distance measurement (mm) from nearest sub-rPe illumination to fovea.
Results

Case 1
case 1 represents data of an 86-year-old female with confirmed dAMD with drusen and gA in both eyes. Both eyes had cataract surgery with implantation of a blue light filtering intraocular lens.
There was no history of other eye operations apart from that. Best in the rPe elevation map, rPe elevations are seen, especially within the 5 mm circle. There are also elevations outside the measurement area, which is indicated by a warning message. The rPe elevations indicating drusen increase between the two visits (see Figure 1) .
Quantitative conclusions are presented in the calculation analysis in the second screen (see Figure 2 ).
second screen analysis shows the 'rPe profile' which integrates rPe elevation map and sub-rPe illumination: the sub-rPe illumination is overlaid on the rPe elevation and shown as an outline. This slab shows the location of the fovea with a dot marking and a circle corresponding to 5 mm in diameter centred on the fovea. furthermore, calculated values are presented in a table (see Figure 2) . calculated values show that from July 2011 until January 2012 the drusen area increased by 0.4 mm (23.5 % change) within the 5 mm circle, whereas drusen volume increased from 0.06-0.07 mm 3 . in addition, the atrophic area changed from 0.6-0.7 mm 2 , which is within the test/retest variability for these measurements and thus could be regarded as measurement noise rather than real change (see Figure 2) .These results correlate well with our clinical observation. The Patient report shows all relevant data including rPe elevation map (1), sub-rPe slab (2), rPe profile (3) and the calculation analysis (see Figure 3A and B). 
) Retinal pigment epithelium (RPE) elevation map overlaid on fundus image; (2) Circles on the RPE elevation map centred on the fovea location; (3) Sub-RPE slab with overlaid segmentation of sub-RPE illumination; (4) Horizontal tomogram showing RPE elevation segmentation line; (5) Fovea is marked as a red dot; line from fovea connecting closest sub-RPE illumination area. On the left side, data of prior visit are provided for direct comparison with data of the last visit (right side).
Figure 2: Advanced RPE Analysis of Case 1 -Second Screen Analysis Exhibiting the RPE Profile™, an Image that Combines the RPE Elevation Map and the Sub-RPE Illumination Segmentation
The
sub-retinal pigment epithelium (RPE) illumination segmentation is overlaid on the RPE elevation map and shown with an outline. A table with calculated values of RPE elevation (area and volume) and atrophic area as well as a calculation of current minus prior and percentage change is also provided. For direct comparison, data of prior visit are provided on the left side, data of the last visit on the right side.
This is another typical case of dAMD in both eyes. in the left eye (see between visits are easily detectable and can be followed over time.
Another major advantage of sD-ocT imaging lies in using only one type of scan for documenting both en face and cross-sectional images of the retina. it therefore provides more detailed insight in retinal alterations of gA patients than fAf, which has already been described. [25] [26] [27] As on the first screen analysis, the fundus image is presented along with the corresponding B-scans, which offers the opportunity to comfortably gather detailed information about the retinal structural changes in these areas (see Figure 1 ). This context it is of utmost importance to define and evaluate reliable and reproducible parameters for grading AMD using sD-ocT. As the new software tool allows for objective and automated measurements, large patient populations can be monitored easily. in this respect it is also advantageous that sD-ocT images based on former cirrus hD-ocT software can be re-evaluated with the new analysis tool. furthermore, it has already been described that the junctional zone of gA is the site of disease activity and will be the target for effective therapeutic strategies against dAMD. 23 
